All-Atom Molecular Dynamics Simulation of Bacterial Multidrug Efflux Transporters AcrB  by Yamane, Tsutomu & Ikeguchi, Mitsunori
Wednesday, February 24, 2010 685abiosensor system with defined physicochemical properties is needed. One
promising approach is the immobilization of MRP-containing proteolipo-
somes on functionalized surfaces. We report a new system for immobilizing
biotin-doped proteoliposomes via the well-known biotin-streptavidin interac-
tion on gold surfaces functionalized with a self assembled monolayer (SAM)
of a binary thiol mixture. The SAM composed of a hydroxy-terminated 16-
carbon alkanethiol and its biotinylated derivative protects the gold surfaces
from unspecific adsorption and allows the immobilization of defined quanti-
ties of streptavidin. Proteoliposomes made from natural lipid compositions
and doped with a biotinylated anchor lipid can readily be tethered to these
surfaces. By thorough biophysical characterization using quartz crystal mi-
crobalance (QCM), atomic force microscopy (AFM) and fluorescence tech-
niques all experimental parameters were optimized for application in biosen-
sor systems. We successfully immobilized intact proteoliposomes containing
the reconstituted human ABC transporter MRP3 on the described surfaces.
Our system allows the investigation of ABC transporters by a variety of sur-
face-enhanced techniques ranging from AFM and QCM to impedance spec-
troscopy and surface plasmon resonance based methods under well-defined
conditions closely mimicking the protein’s natural environment.
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The existence of multidrug transporters accounts for the multidrug resistance of
bacteria encountered in the treatment of many infectious diseases. The recently
solved crystal structure of AcrB, a major multidrug exporter in Escherichia coli,
suggests a functionally rotating mechanism for such an efflux system [1]. Ac-
cording to this mechanism, each protomer of the trimer stays in one of the three
states in an asymmetric way, and exclusively binds and extrudes drugs by ac-
cessing ‘‘Binding’’ state sequentially. To testify such a hypothesis, we have
performed molecular dynamics simulation of the ‘‘porter’’ domain of AcrB
around native state. The system was coarse-grained by using one bead posi-
tioned on Ca atom to represent each residue, and the energy function was de-
scribed by the multiple-basin model [2]. In this work we realized, for the first
time, triple-basin energy landscape for each protomer, by which frequent con-
formational change was simulated. Using this model, we calculated the config-
uration distribution of the trimer in equilibrium based on various energy land-
scapes, and the obtained phase diagram could be used to elucidate the
mechanism of protein function. Further investigation includes the consideration
of an explicit ligand bound in the ‘‘binding’’ protomer by hydrophobic interac-
tion, and the direct simulation of functional rotation and exportation of ligand,
details of which will be presented on the meeting.
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Multidrug efflux transporters cause for antimicrobial resistance in the chemo-
therapy of cancer and antibiotic treatment of numerous different bacterial infec-
tions. In E. coli, it is known that the tripartite multidrug efflux system (AcrB/
AcrA/ TolC) exists, and AcrB resides in the inner membrane region and take
part in substrate recognition and energy transduction for drug export through
proton transfer. Recently, x-ray structures provided that AcrB forms trimeric
protein where each subunit is different conformation, ‘‘binding state’’, ‘‘extru-
sion state’’ and ‘‘access state’’. These results suggest that drugs are exported by
a three-step structural change. In the present study, we performed a series of all-
atom molecular dynamics (MD) simulations of AcrB-membrane-water system
and analyzed the structural change mechanism among three subunits.
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P-glycoprotein (P-gp) is an efflux drug transporter and member of the ATP-
binding cassette (ABC) superfamily, encoded by the ABCB1 (MDR1) gene.
P-gp is located in tissues important in drug disposition, including intestine,
liver, kidney, and blood-brain barrier. Due to its wide tissue distribution andbroad substrate specificity, P-gp is important in drug disposition. P-gp is known
to transport a wide variety of structurally and functionally different drugs, but
the mechanism for binding and transport is poorly understood. The ABCB1
gene is polymorphic and single nucleotide polymorphisms (SNPs) are known
to alter transport via mechanisms that are unclear. Our goal is to utilize bio-
physical and computational methods to understand structure-function relation-
ships in ABCB1 wild-type and its variants. We have built a wild-type human P-
gp homology model based on the recently published mouse crystal structure
(Aller et al., Nature, 2009), and homology models for ABCB1 SNPs
1199G>A (S400N), 1199G>T (S400I), 2677G>T (A893S), 2677G>A
(A893T), and 2677G>C (A893P) using SYBYL8.0 software. Our model pre-
dicts that human P-gp has 12 transmembrane helices and an overall prolate
shape, ~150x60A˚, with a depth of ~60A˚ perpendicular to, ~40A˚within, ~30A˚
above, and ~80A˚ below the membrane. The two intracellular nucleotide-bind-
ing domains are separated by ~20A˚ in the nucleotide-free state and move into
contact in the nucleotide-bound state. We demonstrated that polymorphisms al-
ter the secondary structure of P-gp. We have also modeled the hypothesized
ATP-switch mechanism for P-gp transport and developed a visualization of
this movement. We plan to incorporate wild-type and variant P-gp into lipid-
based nanodiscs to study differential substrate binding and changes in confor-
mation using single-molecule fluorescence. We will correlate these results, and
those from in vitro transport studies, with pharmacophore modeling and QSAR
studies to further understand the functional significance of genetic variation in
ABCB1.
3572-Pos
Functional Rotation of the Transporter AcrB: The Essentials of Peristaltic
Motion and Subsequent Substrate Extrusion
Robert Schulz1,2, Attilio Vittorio Vargiu2, Francesca Collu2,
Ulrich Kleinekatho¨fer1, Paolo Ruggerone2.
1Jacobs University Bremen, Bremen, Germany, 2CNR-SLACS and
Dipartimento di Fisica, Universita’degli Studi di Cagliari, Monserrato (CA),
Italy.
Bacteria, such as E. coli, use multidrug efflux pumps to export toxic substrates
through their cell membranes, including antibiotics. The RND transporter of
the AcrAB-TolC efflux pump is able to export structurally and chemically dif-
ferent substrates via a functional rotation. The three major states of this rotation
cycle were found in several asymmetric crystal structures. After initially ana-
lyzing the basic mechanisms of opening of the TolC channel [1] and of sub-
strate extrusion by AcrB [2] separately, we have continued the analysis of
the latter one. Thereby, we have focused both on the local interactions between
substrate and protein, the properties of the extrusion pathway, as well as the
principal subdomain movements which lead to the peristaltic motion. Further-
more, we have investigated the possibility to pull the substrate from the final
state of the previous simulations out of the exit gate to estimate whether the
substrate is already free to leave the protein via diffusion, which is usually be-
yond the time scale of computer simulations.
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In order to directly observe conformational change in the mitochondrial citrate
transport protein (CTP), we measured, in the presence and absence of inhibi-
tors, the EPR spectra of spin-labeled single-Cys CTP mutants that were recon-
stituted in liposomes. We selected spin-label locations to report on substrate
binding sites 1 and 2 (i.e., 187, 183, and 179), binding site 2 (39), TMDIII
pointing away from the transport pathway (118), and a matrix-facing hydro-
philic loop (47). In the absence of inhibitor, the EPR lineshapes show resi-
due-dependent variations in mobility. Addition of external 1,2,3-benzenetricar-
boxylate (BTC), the defining inhibitor of the CTP, caused a modest, residue-
dependent decrease in the mobile component and a concomitant increase in
the immobile component. Addition of compound 792949, a novel, purely com-
petitive inhibitor that we previously identified via high throughput in silico
screening using the homology-modeled CTP in its cytosolic-facing conforma-
tion, yielded EPR spectra that contain a substantial increase in the immobile
component at each location. We conclude that the two inhibitors cause CTP
to assume different conformations, which vary significantly in their extent of
immobilization.
